生物科技公司Twist Bioscience Corporation(TWST)股价今日盘中大涨5.04%,引发市场广泛关注。虽然并无重大利好消息,但公司最新财报表现优异,或成为推动股价上涨的主要原因。
据报道,TWST在最近的财报期内实现营收3.13亿美元,虽然仍处于亏损状态但每股亏损收窄至3.60美元,毛利高达1.33亿美元,财务数据远超预期。此外82%的机构分析师给予TWST股票"买入"评级,反映出市场对公司前景的看好。
分析人士指出,生命科学和合成生物学行业前景广阔,疫情后医疗健康领域需求增长,TWST作为该领域的先驱之一,有望借助行业发展红利持续实现良好业绩增长。公司高管团队经验丰富,在DNA合成技术领域处于领先地位,将为未来发展奠定坚实基础。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.